Skip to main content
芭薇股份 logo

芭薇股份 — Investor Relations & Filings

Ticker · 920123 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 240 across all filing types
Latest filing 2025-04-27 Major Shareholding Noti…
Country CN China
Listing Beijing Stock Exchange 920123

About 芭薇股份

https://www.gzbawei.com/

Guangdong Bawei Biotechnology Corp., Ltd. is a comprehensive beauty and personal care solution provider specializing in research, development, production, and testing. The company offers integrated OEM, ODM, and OBM services, covering a wide range of product categories including skincare, hair care, body care, and makeup. Bawei is recognized for its commitment to scientific innovation, operating advanced R&D laboratories and an independent third-party testing center that ensures product safety and efficacy. By leveraging automated production lines and a rigorous quality management system, the company serves a diverse portfolio of domestic and international brands. Its core focus remains on delivering high-quality, customized formulations and manufacturing excellence to meet evolving consumer demands in the global beauty market.

Recent filings

Filing Released Lang Actions
持股5%以上股东减持股份结果公告
Major Shareholding Notification Classification · 95% confidence The document is a formal announcement from Guangdong Bawei Biotechnology Co., Ltd. regarding the results of a shareholding reduction by a shareholder holding more than 5% of shares. It details the shareholder's name, shareholding before and after reduction, reduction method, period, price range, and completion status. The document is short (1036 characters) and focuses on the completion of a shareholding reduction plan, which aligns with the definition of a Major Shareholding Notification (MRQ) as it reports changes in significant share ownership levels crossing thresholds. There is no indication that this is a full financial report, audit, or other types of filings. Therefore, the correct classification is MRQ with high confidence.
2025-04-27 Chinese
关于天职国际会计师事务所（特殊普通合伙）履职情况评估报告
Audit Report / Information Classification · 95% confidence The document is an evaluation report on the performance of the accounting firm Tianzhi International Certified Public Accountants (Special General Partnership) for the company's 2024 annual audit work. It discusses the auditor's qualifications, independence, audit procedures, and the company's assessment of the auditor's performance. The document does not contain the actual audit report or financial statements but is an assessment of the auditor's fulfillment of duties. The document length is short (1325 characters) and it is not a full annual report or audit report itself. It is a standalone audit-related report focusing on the auditor's performance and compliance with auditing standards. Therefore, it fits best under the category of Audit Report / Information (AR). FY 2024
2025-04-24 Chinese
2024年度独立董事述职报告（蔡光云）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Work Report" for the year 2024 by an independent director of Guangdong Bawei Biotechnology Co., Ltd. It details the director's activities, attendance at board and shareholder meetings, communication with internal audit and accounting firms, and efforts to protect investor rights. The content is a narrative report on the director's duties and performance rather than financial data or audit results. It does not contain financial statements or audit opinions. This type of document is typically classified under Board/Management Information (MANG) as it relates to governance and management reporting on board activities, especially concerning independent directors.
2025-04-24 Chinese
万联证券股份有限公司关于公司2024年年度募集资金存放与实际使用情况的核查意见
Regulatory Filings
2025-04-24 Chinese
拟续聘2025年度会计师事务所公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the proposed reappointment of an accounting firm (auditor) for the 2025 fiscal year. It details the auditor's background, independence, audit fees, and the approval process by the board and supervisory committee. It does not contain any actual audit report, financial statements, or audit results. The document length is 3153 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document is best classified as an Audit Report / Information announcement (AR) because it relates to audit matters but is not the audit report itself. However, since it is primarily an announcement of auditor appointment and related information, and not the audit report or results, the best fitting category is AR (Audit Report / Information). FY 2025
2025-04-24 Chinese
第四届监事会第三次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Guangdong Bawei Biotechnology Co., Ltd. It details the meeting date, attendance, and the approval of various proposals related to the company's annual report, financial statements, budget, dividend plan, audit firm appointment, internal control report, and other corporate governance matters. The document references multiple detailed reports and announcements published separately on the Beijing Stock Exchange information disclosure platform, indicating that this document itself is not the full reports but a meeting resolution summarizing approvals and decisions. The document length is 3231 characters, which is relatively short and consistent with an announcement rather than a full report. The content is focused on the Supervisory Board meeting resolutions rather than the full annual report or financial statements. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a formal announcement of meeting resolutions and approvals, not the actual reports or financial data themselves.
2025-04-24 Chinese

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.